Varian Medical (NYSE:VAR) said today that it closed the $283 million deal to acquire Cancer Treatment Services International and its network of oncology centers on the Indian subcontinent. When it announced the buyout last month, Varian said that it hoped to increase its expertise in cancer care center operations. The deal was financed via a credit facility […]
Radiosurgery/Radiation therapy
iCad prices $9m offering
iCad (NSDQ:ICAD) today priced a stock offering that’s slated to gross just more than $9.0 million. The Nashua, N.H.-based cancer detection and radiation therapy devices maker said it plans to float more than 1.6 million shares at $5.50 apiece, for expected net proceeds of about $8.3 million. The offering includes a 30-day underwriters option on […]
Misonix gains FDA clearance for ultrasonic surgical platform
Misonix (NSDQ:MSON) said today that it received FDA 510(k) clearance for a new ultrasonic surgical platform. The Nexus platform combines all the features of Misonix’s existing solutions, including BoneScalpel, SonicOne and Sonastar, into a single, fully integrated platform that was also designed to accommodate future solutions. The Nexus platform is driven by a new […]
Argon Medical Devices buys its U.K. distributor
Argon Medical Devices (Frisco, Texas), an OEM manufacturer of specialty medical products, custom components and drainage catheters, announced that it has completed the acquisition of Mana-Tech, Ltd., its exclusive distributor for the United Kingdom and Ireland. Mana-Tech (Burton-on-Trent, England) is a distributor of biopsy products and radiology consumables in the U.K. The entire Mana-Tech team, including its […]
FDA approves Novocure’s NovoTTF-100LTM plus chemo for mesothelioma
NovoCure (NSDQ:NVCR) announced that it has received FDA approval for its NovoTTF-100L system with chemotherapy for treating a type of mesothelioma. NovoTTF-100L is a non-invasive, antimitotic cancer treatment designed to deliver electric fields at special frequencies to disrupt solid tumor cancer cell division. Approved under a humanitarian device exemption, NovoTTF-100L and pemetrexed plus platinum-based chemotherapyis indicated […]
Varian Medical to pick up Cancer Treatment Services Int’l for $283m
Varian Medical (NYSE:VAR) said today that it inked a deal to acquire Cancer Treatment Services International for $283 million. Privately held CTSI operates the Hyderabad-based American Oncology Institute and 10 multidisciplinary radiation, medical and surgical oncology cancer centers across the Indian subcontinent and a U.S.-based oncology solutions division, Palo Alto, Calif.-based Varian said. Varian said that […]
Varian acquires CyberHeart, inks deal with China’s Shangdong Cancer Hospital
Varian Medical (NYSE:VAR) said today that it acquired privately-held CyberHeart and its cardiac radioablation tech, and that it inked a cooperative deal with China’s Shangdong Cancer Hospital for proton therapy applications and research. Palo Alto, Calif.-based Varian said that early clinical evidence from studies of CyberHeart’s cardiac radioablation technology indicated it “has the potential to offer […]
Elekta files patent suit against Zap Surgical
Surgical system maker Zap Surgical Systems said yesterday that it is facing a patent infringement lawsuit from Elekta (STO:EKTA B) related to its Zap-X gyroscopic radiosurgery platform. San Carlos, Calif.-based Zap Surgical said that said that it is facing a lawsuit in the U.S. District Court for the Northern District of California asserting that its Zap-X […]
Varian Medical wins $7m DoD contract
Varian Medical (NYSE:VAR) has won an approximately $7.1 million delivery order against a five-year basic ordering agreement to supply the U.S. Department of Defense with two linear accelerator systems, according to a recently released DoD posting. The deal comes through a one-year contract with no option periods, and was a competitive acquisition with two offers received […]
ViewRay inks Australian, Canadian distro deals
ViewRay (NSDQ:VRAY) said this week that it inked distribution deals in both Australia and Canada for its MRIdian MRI-guided radiation therapy system. The MRIdian system is designed to integrate full-time MR imaging, cobalt radiation delivery and software automation for cancer treatment throughout the body, the Cleveland, Ohio-based company said. In a release posted yesterday, ViewRay said […]
Varian Medical joins embolic therapy tech dev ABK Biomedical’s $30m Series B
Varian Medical (NYSE:VAR) has joined a $30 million Series B round of financing for embolic therapy tech developer ABK Biomedical. Palo Alto, Calif.-based Varian Medical Systems led the round alongside F-Prime Capital, Halifax, Nova Scotia-based ABK Biomedical said. “ABK has a unique approach to address a large unmet need for patients with non-resectable liver tumors. This […]